title: Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin.
authors.affiliation: Department of Neurology, Mount Sinai Medical Center, New York, New York 10029, USA.
authors.forename: M F
authors.initials: MF
authors.lastname: Brin
authors.forename: A
authors.initials: A
authors.lastname: Blitzer
authors.forename: C
authors.initials: C
authors.lastname: Stewart
mesh_terms: D000328:Adult; D017668:Age of Onset; D018726:Anti-Dyskinesia Agents / Q000008:administration & dosage*; D000974:Antibodies, Antinuclear / Q000097:blood; D001905:Botulinum Toxins / Q000008:administration & dosage*; D003413:Cricoid Cartilage; D004421:Dystonia / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013035:Spasm / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D014826:Vocal Cord Paralysis / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D014832:Voice Disorders / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology
chemical_list: D018726:Anti-Dyskinesia Agents; D000974:Antibodies, Antinuclear; D001905:Botulinum Toxins